Chronic lymphocytic leukemia (CLL) is the most common adult leukemia in western countries and is characterized by the gradual accumulation of mature B lineage-specific markers such as CD19, CD20, and CD23 and additionally the CD5 antigen in lymphoid tissues, bone marrow, and peripheral blood (PB). Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.